Louisiana State University Research announced on the 19th research staff report that contained in green tea The active ingredient EGCG polyphenols may slow prostate cancer growth.

researchers in the United States a new "study of cancer prevention," the journal reported that they were aged 26 to 41-year-old among 72-year-old patients with prostate cancer were tested. These patients daily doses of 4 capsules rich in EGCG and prostate surgery in the day of cessation of drug use. From their medication 12-73 days ranged from an average of 34.5 days.

researchers found that the serum of patients with prostate cancer used to measure the growth of three kinds of markers have decreased levels, of which the level of hepatocyte growth factor dropped by an average of 18.9%, vascular endothelial growth factor levels 9.9%, prostate-specific antigen level dropped by an average of 10.4%. Some patients with serum hepatocyte growth factor and vascular endothelial growth factor levels dropped even more than 30%. These patients did not appear the basic reaction and liver function are normal.

led the research, the Louisiana State University Health Science Center professor, said James Giuliano, the active ingredient in green tea to restrict the rapid growth of cancer cells, but not necessarily to reduce the tumor. However, green tea really can be used as chemotherapy and radiotherapy a useful complement. Giuliano also said that their study was only small-scale tests, the results related to large-scale study also need to be confirmed.

provided by American Cancer Society data show that prostate cancer is currently the second largest U.S. male cancer cause of death. The association is expected in 2009, the U.S. men died of prostate cancer will reach 27,000 people, new cases will reach 192,000 cases.